|
Fusion gene ID: 9437 |
FusionGeneSummary for DCP2_IL17B |
Fusion gene summary |
Fusion gene information | Fusion gene name: DCP2_IL17B | Fusion gene ID: 9437 | Hgene | Tgene | Gene symbol | DCP2 | IL17B | Gene ID | 167227 | 27190 |
Gene name | decapping mRNA 2 | interleukin 17B | |
Synonyms | NUDT20 | IL-17B|IL-20|NIRF|ZCYTO7 | |
Cytomap | 5q22.2 | 5q32 | |
Type of gene | protein-coding | protein-coding | |
Description | m7GpppN-mRNA hydrolaseDCP2 decapping enzyme homologhDpcmRNA-decapping enzyme 2nudix (nucleoside diphosphate linked moiety X)-type motif 20 | interleukin-17Bcytokine-like protein ZCYTO7interleukin 20interleukin-17 betaneuronal interleukin-17 related factor | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q8IU60 | Q9UHF5 | |
Ensembl transtripts involved in fusion gene | ENST00000515408, ENST00000389063, ENST00000543319, ENST00000504961, | ENST00000505432, ENST00000261796, | |
Fusion gene scores | * DoF score | 6 X 5 X 5=150 | 3 X 1 X 3=9 |
# samples | 8 | 3 | |
** MAII score | log2(8/150*10)=-0.906890595608519 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: DCP2 [Title/Abstract] AND IL17B [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DCP2 | GO:0006402 | mRNA catabolic process | 21070968 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | ACC | TCGA-P6-A5OF-01A | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000515408 | ENST00000505432 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
5CDS-5UTR | ENST00000515408 | ENST00000261796 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
5CDS-5UTR | ENST00000389063 | ENST00000505432 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
5CDS-5UTR | ENST00000389063 | ENST00000261796 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
5UTR-5UTR | ENST00000543319 | ENST00000505432 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
5UTR-5UTR | ENST00000543319 | ENST00000261796 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
intron-5UTR | ENST00000504961 | ENST00000505432 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
intron-5UTR | ENST00000504961 | ENST00000261796 | DCP2 | chr5 | 112328467 | + | IL17B | chr5 | 148756588 | - |
Top |
FusionProtFeatures for DCP2_IL17B |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
DCP2 | IL17B |
Decapping metalloenzyme that catalyzes the cleavage ofthe cap structure on mRNAs (PubMed:12417715, PubMed:12218187,PubMed:12923261, PubMed:21070968). Removes the 7-methyl guaninecap structure from mRNA molecules, yielding a 5'-phosphorylatedmRNA fragment and 7m-GDP (PubMed:12486012, PubMed:12923261,PubMed:21070968). Necessary for the degradation of mRNAs, both innormal mRNA turnover and in nonsense-mediated mRNA decay(PubMed:14527413). Plays a role in replication-dependent histonemRNA degradation (PubMed:18172165). Has higher activity towardsmRNAs that lack a poly(A) tail (PubMed:21070968). Has no activitytowards a cap structure lacking an RNA moiety (PubMed:21070968).Blocks autophagy in nutrient-rich conditions by repressing theexpression of ATG-related genes through degration of theirtranscripts (PubMed:26098573). {ECO:0000269|PubMed:12218187,ECO:0000269|PubMed:12417715, ECO:0000269|PubMed:12486012,ECO:0000269|PubMed:12923261, ECO:0000269|PubMed:14527413,ECO:0000269|PubMed:18172165, ECO:0000269|PubMed:21070968,ECO:0000269|PubMed:26098573}. | Stimulates the release of tumor necrosis factor alphaand IL-1-beta from the monocytic cell line THP-1. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for DCP2_IL17B |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for DCP2_IL17B |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
DCP2 | PSMB1, UPF1, UPF2, UPF3A, DCP1A, EDC4, ELAVL1, TRIM21, ZFP36, EDC3, DCP1B, MMS19, POLA2, NAGK, ABCE1, ANGEL2, AP1M1, ARMCX5, CAPN2, DARS2, EIF5A, ELP3, FANCD2, FBXO3, GARS, GFPT1, GFPT2, GGCX, GGT7, GLUD1, GTPBP2, IDE, IKBKAP, INTS7, PFKM, PGM3, PHKB, POLD3, QPCTL, SFXN2, SLC25A10, SQSTM1, TARS, TRMT2A, TRRAP, FAM96B, NXPH3, SPACA1, COLEC10, PCBP3, TUBB8, EEF1A2, GAPDHS, GBAS, CRKL, PPP1R35, MTOR, ZFP36L1, F9, LRRC32, CHRM3, PDCD1 | IL17B | ENO2, IL17RB |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for DCP2_IL17B |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for DCP2_IL17B |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |